# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Jan 11, 2017

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2017-01-11
- Accepted by EDGAR: Jan 11, 2017, 14:08 ET
- Period: 2017-01-10
- Accession: 0000875320-17-000007
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532017000007/oncology8-kjan2017.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532017000007/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532017000007/oncology8-kjan2017.htm

Filed Jan 11, 2017.
Source: SEC EDGAR, the filing index for accession 0000875320-17-000007. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.